Back

Long-term PCI outcomes in chronic versus acute coronary syndromes: 5-year results of the TARGET All Comers trial

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: RCT in acute coronary syndromes: new developments Revascularisation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speakers

Photo
Doctor Alexandra Lansky

Yale School of Medicine, New Haven (United States of America)

Photo
Doctor Thomas Johnson

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Sonothrombolysis delivered before percutaneous coronary intervention improves myocardial salvage in ST elevation myocardial infarction
Doctor D. Nirthanakumaran (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Remote ischemic peri-conditioning suppressed the activation of cardiac sympathetic nervous system in patients with acute myocardial infarction: a randomized controlled trial
Mr T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Adjunctive cilostazol in patients with acute ST-elevation myocardial infarction: a multicenter, randomized, open-label, phase 4 trial
Doctor S. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Ticagrelor induces ischaemic preconditioning in coronary artery disease
Doctor D. D'Amario (Novara, IT)
Abstract Slides
Presentation thumbnail
Sonothrombolysis with microbolus administration of perfluoropropane as point of care therapy for STEMI patients
Associate Professor P. Mathen (Vellore, IN)
Abstract Slides Video

Access the full session

Session thumbnail
RCT in acute coronary syndromes: new developments

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent for de novo culprit lesion in acute coronary syndromes: a report from nationwide registry in japan
thumbnail
Congress Presentation
Comparison of target vessel revascularization rates between biodegradable and durable polymer drug-eluting stents: a retrospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources